Literature DB >> 9246221

Atypical neuroleptic malignant syndrome associated with clozapine treatment.

M Amore1, N Zazzeri, D Berardi.   

Abstract

Clozapine is an atypical neuroleptic drug that was initially thought not to cause neuroleptic malignant syndrome (NMS). The authors report a case of NMS associated with clozapine use, developed in a patient without previous history of NMS. Considering that 13 such cases (including ours) have been reported so far, NMS should be considered in the differential diagnosis of a febrile patient treated with clozapine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246221     DOI: 10.1159/000119344

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  4 in total

1.  Rechallenging clozapine after neuroleptic malignant syndrome.

Authors:  Emaya Anbalagan; Muaid Ithman; John Lauriello
Journal:  Psychiatr Q       Date:  2014-09

2.  Resolution of symptoms in neuroleptic malignant syndrome.

Authors:  Yvonne D S Pereira; Ashish Srivastava; Bramhanand S Cuncoliencar; Nayana Naik
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

Review 3.  Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.

Authors:  Martino Belvederi Murri; Argentina Guaglianone; Michele Bugliani; Pietro Calcagno; Matteo Respino; Gianluca Serafini; Marco Innamorati; Maurizio Pompili; Mario Amore
Journal:  Drugs R D       Date:  2015-03

4.  Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association.

Authors:  Siddharth Sarkar; Nitin Gupta
Journal:  BJPsych Bull       Date:  2017-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.